News - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

News


Pharmaceutical Technology Europe
Volume 24, Issue 8

News bites

Investigation at Roche

The EMA has launched an investigation into Roche after an inspection found that thousands of potential safety reports, including 15161 deaths, connected to Roche medicines had not been evaluated to determine whether they should be reported to regulators as adverse drug reactions.
http://www.pharmtech.com/RocheReporting

GSK Pleads Guilty

GlaxoSmithKline has agreed to plead guilty and pay $3 billion (2.4 billion Euros) to resolve criminal and civil liability resulting from the unlawful promotion of certain drugs, failure to report safety data and alleged false price reporting practices. According to the Justice Department, it is the largest healthcare fraud settlement in US history.
http://pharmtech.com/GSkGuilty

US Healthcare Reform

The US Supreme Court has upheld the provision of the country's Affordable Care Act. Among other points, the decision means that FDA can continue to implement the new biosimilars programme. Implementation of US reform now depends on who controls the White House and Congress after the elections, as well as individual states implementing the law.
http://www.pharmtech.com/USReform

Merck Restructuring

Merck Serono has revealed its "final efficiency program" for operations in Switzerland, which includes confirmation of the closure of sites in Geneva and Coinsins. The majority of job transfers and cuts are expected to be completed later this year. Closure of the Geneva site is planned for mid-2013 and for 2014 for the Coinsins site.
http://www.pharmtech.com/MerckPlans


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
25%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
36%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology Europe,
Click here